Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06191471
Other study ID # UBalamandAAC
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2023
Est. completion date December 10, 2023

Study information

Verified date December 2023
Source University of Balamand
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

41-year-old previously healthy patient presented with right upper quadrant abdominal pain. Pain started two days prior to presentation when an abdominal ultrasound in a peripheral hospital showed a 10 mm gallbladder stone with normal laboratory tests; however, her pain was resolved on analgesics. Now the pain was persistent and associated with vomiting and laboratory tests showed elevated bilirubin. Laparoscopic cholecystectomy with intraoperative cholangiography was done that showed inflamed gallbladder but with no stones and normal cholangiography. Day one post-operation, while the pain resolved, labs showed elevated liver function tests and hepatitis workup showed acute HAV infection attributing her presentation to HAV induced AAC.


Description:

Introduction: acute acalculous cholecystitis (AAC) is defined as gallbladder inflammation without the presence of stones. Contrary, hepatitis A virus (HAV) causes acute hepatitis A and can present with different symptoms; however, HAV causing and presenting as AAC is rare. Case presentation: 41-year-old previously healthy patient presented with right upper quadrant abdominal pain. Pain started two days prior to presentation when an abdominal ultrasound in a peripheral hospital showed a 10 mm gallbladder stone with normal laboratory tests; however, her pain was resolved on analgesics. Now the pain was persistent and associated with vomiting and laboratory tests showed elevated bilirubin. Laparoscopic cholecystectomy with intraoperative cholangiography was done that showed inflamed gallbladder but with no stones and normal cholangiography. Day one post-operation, while the pain resolved, labs showed elevated liver function tests and hepatitis workup showed acute HAV infection attributing her presentation to HAV induced AAC. Discussion: AAC is usually caused by stasis of the gallbladder due to different causes; however, HAV as the cause of AAC has been reported. While cholecystectomy is the mainstay treatment for AAC, this might not be the case for HAV induced AAC. For instance, unless there is necrotic gallbladder or persistence of symptoms, the AAC can be managed conservatively in this case. Even though our diagnosis was cleared post-operatively, had we know the diagnosis of HAV induced AAC before, we would still opt for surgery due to the severity and persistence of pain. Conclusion: More cases should be reported and more studies should be done to further define the presentation and management of HAV induced AAC.


Recruitment information / eligibility

Status Completed
Enrollment 1
Est. completion date December 10, 2023
Est. primary completion date December 10, 2023
Accepts healthy volunteers
Gender Female
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - acalculous cholecystitis Exclusion Criteria: - calculous cholecystitis

Study Design


Intervention

Other:
Laparoscopic cholecystectomy for hepatitis A induced acute acalculous cholecystitis
Laparoscopic cholecystectomy for hepatitis A induced acute acalculous cholecystitis

Locations

Country Name City State
Lebanon University Of balamand Beirut

Sponsors (1)

Lead Sponsor Collaborator
University of Balamand

Country where clinical trial is conducted

Lebanon, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hepatitis A induced acute acalculous cholecystitis Laparoscopic cholecystectomy for hepatitis A induced acute acalculous cholecystitis 1 month
See also
  Status Clinical Trial Phase
Completed NCT01894321 - The Clinical Outcomes of the Percutaneous Cholecystostomy, Supportive Care Versus Cholecystectomy. N/A